HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody: Fluorescent Precision for Immunoassays

Executive Summary: The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody is a polyclonal secondary antibody, affinity-purified and conjugated to Alexa Fluor 488 for robust fluorescence detection of human immunoglobulins (APExBIO). Its excitation/emission maxima (495/519 nm) enable compatibility with standard FITC filter sets in diverse immunoassays. The antibody demonstrates high specificity and low cross-reactivity due to antigen-based affinity purification (see benchmark analysis). Preclinical studies validate its use for sensitive signal amplification in Western blot, flow cytometry, and immunohistochemistry (Lu et al., 2024). The reagent is supplied at 1 mg/mL in a stabilizing buffer with BSA and sodium azide, ensuring consistent performance and storage stability.

Biological Rationale

Secondary antibodies recognize and bind to the constant (Fc) domain of primary antibodies, facilitating detection, amplification, and quantification of antigen-antibody interactions (Precision in Advanced Immunoassays). The use of a goat anti-human IgG (H+L) antibody allows detection of a broad range of human immunoglobulins, including both heavy and light chains. Alexa Fluor 488 is a green fluorescent dye with high quantum yield and photostability, optimized for sensitive fluorescence detection (excitation: 495 nm, emission: 519 nm). In immunology and vaccine research, such as bivalent mRNA vaccine studies, quantifying human immunoglobulin responses with high sensitivity is essential for evaluating immunogenicity (Lu et al., 2024).

Mechanism of Action of HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody

The HyperFluor™ 488 antibody is a polyclonal reagent generated by immunizing goats with purified human IgG (H+L) fragments. The antibody fraction is affinity-purified using antigen-coupled agarose beads to ensure specificity for human immunoglobulin heavy and light chains. Alexa Fluor 488 is covalently conjugated to the antibody, providing stable, bright fluorescence. Upon binding to the primary antibody (targeting the antigen of interest), the conjugated Alexa Fluor 488 enables detection using fluorescence microscopy, flow cytometry, or plate readers with suitable filter sets. Multiple secondary antibodies can bind a single primary antibody, amplifying signal intensity for improved sensitivity in immunoassays (see molecular specificity).

Evidence & Benchmarks

• Affinity purification via antigen-coupled agarose beads results in high specificity and minimal cross-reactivity to non-human immunoglobulins (APExBIO product data).
• Alexa Fluor 488 conjugation yields excitation/emission maxima of 495/519 nm, compatible with standard FITC filter sets (APExBIO product sheet).
• Demonstrated robust signal amplification in ELISA, Western blot, ICC/IF, IHC-Fr, IHC-P, and flow cytometry at 1:500 to 1:10,000 dilutions (APExBIO, application benchmarks).
• Validated in preclinical vaccine studies for quantifying human IgG responses in animal models, supporting high-titer neutralizing antibody detection (Lu et al., 2024, Table S2).
• Supplied as a 1 mg/mL liquid in PBS, 23% glycerol, 1% BSA, 0.02% sodium azide; storage at 4°C (≤2 weeks) or -20°C (≤12 months) preserves fluorescence (APExBIO technical documentation).

Applications, Limits & Misconceptions

This antibody is optimized for qualitative and quantitative detection of human immunoglobulins in fluorescence-based assays:

• Immunocytochemistry/Immunofluorescence (ICC/IF): Enables visualization of cellular antigens with high sensitivity and low background.
• Western Blotting: Provides strong, specific bands for human IgG targets when used at 1:5,000–1:10,000 dilution.
• Immunohistochemistry (IHC-Fr, IHC-P): Effective for tissue sections, both frozen and paraffin-embedded, with robust fluorescence retention.
• Flow Cytometry: Allows sensitive discrimination of human IgG-expressing cells with minimal spectral overlap.
• ELISA: Delivers quantitative measurement of human antibody responses, including post-vaccination immunogenicity.

For strategic guidance on signal amplification and multiplexed detection, see Illuminating Translational Immunology, which this article builds upon by detailing recent preclinical vaccine validation and workflow optimization.

Common Pitfalls or Misconceptions

• Not suitable for direct detection of mouse or rabbit primary antibodies; use species-matched secondaries for non-human primaries.
• Alexa Fluor 488 is sensitive to photobleaching; minimize exposure to light, especially during long incubations or imaging.
• Repeated freeze-thaw cycles degrade antibody integrity and fluorescence; aliquot upon first use.
• High background may result from insufficient washing or blocking—optimize buffer composition and incubation times.
• Cross-reactivity with non-IgG isotypes is minimal but possible if using non-humanized samples; confirm species specificity.

Workflow Integration & Parameters

For best results, dilute the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody in PBS containing 1% BSA. Typical working dilutions range from 1:500 (immunofluorescence) to 1:10,000 (ELISA, Western blot). Incubate with the primary antibody-bound sample for 1 hour at room temperature, protect from light. Wash thoroughly with PBS-Tween (0.05–0.1%) between steps. For multiplexed detection, ensure spectral compatibility—Alexa Fluor 488 is best paired with dyes like Alexa 594 or Alexa 647 for minimal overlap. Store unused aliquots at -20°C; avoid repeated freeze-thaw. For more on maximizing quantitative signal and reproducibility, this article extends the discussion to molecular specificity and advanced multiplexing.

Conclusion & Outlook

The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody (SKU: K1205) from APExBIO represents a robust, high-sensitivity tool for fluorescent detection of human immunoglobulins in a wide range of applications. Its validated performance in preclinical vaccine studies and advanced immunoassays positions it as a core reagent for translational and clinical research (Lu et al., 2024). Ongoing developments in multiplexed immunoassays and single-cell analysis will further expand its utility. For technical details and ordering, visit the official product page.